Furthermore, this study created a three-gene prognostic marker consisting of an m6A methylation regulatory factor, namely, METTL16, YTHDF1, and ZC3H13, and the calculated riskscore had a good predictive effect on cervical cancer patients. The gene discussed is METTL16; the disease is cervical carcinoma.